Differences in the histological distribution of lung carcinoma between men and women, which cannot be fully explained by differences in smoking habits, 1 and a possibly greater susceptibility of women to tobacco carcinogens than men, 2, 3 indicate that sex-specific hormones may play a role in the genesis of lung cancer. Siegfried 4 hypothesized that oestrogens may possibly influence lung cancer development, either through direct promotion by oestrogen of cell proliferation in the lung, or as a result of the influence of estrogen on lungcarcinogen metabolism or development of lung diseases that predispose to lung cancer. Evidence for an association between hormonal factors and lung cancer among women is available from several lines. First, possible biological evidence was given by some experimental studies indicating the presence of steroid receptors in some lung tumour types. [5] [6] [7] [8] Steroids such as glucocorticoids and oestrogens regulate the differentiation and metabolism of pulmonary epithelial cells. Second, a familial aggregation of cancers of the reproductive system among female lung cancer patients 9,10 in addition to an increased risk of lung cancer in female survivors of a primary cancer of the reproductive organs [11] [12] [13] [14] [15] [16] [17] have been described, indicating a possibly endocrine-related common aetiology of cancers of the lung and the reproductive organs. Third, some menstrual [18] [19] [20] and reproductive factors 18, [21] [22] [23] Background Gender differences in the histological distribution of lung carcinoma and a possibly greater susceptibility of women than men to tobacco carcinogens, suggest a possible influence of sex-specific hormones. This study examines endocrine factors and risk of lung cancer among women by smoking status and histology.
contraceptives (OC) was suggestive of a reduced lung cancer risk. 23 Inconsistent results have been provided with respect to oestrogen replacement therapy. 21, [24] [25] [26] A positive synergism between smoking and oestrogen replacement therapy was reported by Taioli and Wynder 21 and was hypothesized as a possible explanation for a heightened smoking risk of women compared with men.
The aim of the present analysis of the data of a case-control study on lung cancer in Germany was to examine the relation of various hormonal factors in the aetiology of lung cancer in women. Particular emphasis was given on estimating these effects separately in smokers and non-smokers and for different histological types. Findings of this study on other risk factors have been published previously. [27] [28] [29] [30] 
Materials and Methods
Data were derived from a case-control study of lung cancer and indoor radon conducted between 1990 and 1996 in Germany. The data collection methods have been described previously. 29, 30 In brief, newly diagnosed (ഛ3 months) cases with histologically or cytologically confirmed lung cancer as a primary tumour were recruited from 15 study hospitals. Inclusion criteria for cases were: (1) an age Ͻ76 years at the date of interview; (2) current residence in the study area; (3) residence in Germany Ͼ25 years; (4) an adequately good clinical state to face an interview of around 1.3 hours duration; and (5) no suspicion of pulmonary metastases from a different tumour. Population controls satisfying inclusion criteria (1)- (4) were randomly selected from either residency registries or by modified random digit dialling and were frequency matched to the cases on sex, age, and region. The response rate of cases and controls fulfilling the inclusion criteria was 76% and 41%, respectively.
A total of 4276 cases (3465 men and 811 women) and 4629 controls (3717 men and 912 women) were personally interviewed by trained interviewers. A structured questionnaire was used to obtain information on demographic characteristics, residential history, active and passive (non-smokers only) smoking history, job history, personal and family medical history, dietary habits, and endocrine factors. Subjects were defined as smokers if they had ever smoked regularly (at least one cigarette per day) for ജ6 months. Active and former smokers were summarized as smokers and were compared with non-smokers. One-year radon measurements were performed in the current residence. 30 Among women, detailed information on hormonal factors such as age at first and last menstrual period, average length of menstrual cycle, age at first pregnancy, and number of full-term pregnancies was collected. Menopausal status could be determined only indirectly by cessation of menstrual periods. Women reporting that they had still their menstrual periods at the date of interview were defined as premenopausal women. Those reporting cessation of menstruation were asked about age at last menstrual period defined as age at menopause in the analyses and about cause of menopause (natural, surgery, radiation therapy, hormonal therapy, or others) including information on age at genital surgery. To assess the role of exogenous hormones women were asked about having ever used OC, age at first use, and duration of use in years. In addition, they were asked whether they had ever used hormones other than OC as, for example, oestrogen replacement therapy in menopause. For positive response, information was recorded on age at first use, and duration of use in years, but not on type of hormones or dosage.
The statistical analyses were based on multivariate techniques for case-control studies. Conditional logistic regression models were used to estimate odds ratios (OR) and 95% CI with strata for age and region and adjusting for educational level (Ͻ10 years, ജ10 years of school attendance), cumulative tobacco smoke (log(packyear+1)), and years since stopping smoking (current smoker/quit Ͻ5 years ago or quit Ͼ5 years ago). As additional potential confounders for the association of endocrine factors and lung cancer risk we quantified variables for occupational exposure to known or suspected lung carcinogens as described previously, 28 exposure to environmental tobacco smoke in terms of the summary indicator of ETS-exposure (low, medium, or high) for non-smokers, 29 and time-weighted average radon exposure in the current residence as continuous variable. 30 Since risk estimates were little affected by these confounder variables we present OR adjusted for age, region, smoking, and education only. Trend tests were performed using the continuous variable in the regression model and presenting the corresponding twosided P-value. For categorization of variables tertiles of the distribution among controls was used. Subgroup analyses were performed after stratification for smokers and non-smokers and by histological type using unconditional logistic regression models. Potential differences in OC and hormone replacement therapy (HRT) use or other factors between women from East and West Germany were considered by repeating all analyses separately for each study area and discussing differences if present.
Results
The present analysis included 811 female cases and 912 female controls. Demographic parameters and the distribution of some potential confounders were given in Table 1 . The mean age was 60 years among the cases and 59 years among the controls. The educational level tended to be higher among controls as compared with cases. A substantially higher proportion of female controls reported to have never smoked (65%) than among cases (31%). Among smokers more cases were current smokers, smoking more cigarettes per day for a longer duration, than controls. The main histological type was adenocarcinoma (48%), followed by small cell lung cancer (26%), squamous cell carcinoma (21%), and other tumour types (5%). Table 2 shows the OR for menstrual and reproductive factors. No significant differences between cases and controls in terms of age at first menarche, length of menstrual cycle, and number of full-term pregnancies were observed. Lung cancer risk significantly decreased with increasing age at first pregnancy. To see whether women without pregnancy behave like women with late age at pregnancy, as is known for breast cancer, we additionally included women without pregnancy in the model. The corresponding risk estimate, however, was similar to that of women with young age at pregnancy. The ratio between postmenopausal and premenopausal women in the case group was higher than that in the control group. Among women who experienced natural menopause, no trend in risk with increasing age at menopause was observed. The same holds true when age at both natural and surgical menopause was considered (OR = 1.0, 1.1, 0.9, 1.0 for Ͻ45, 45-49, 50-52, ജ53 years of age at menopause, respectively). Mean age at natural menopause was 49.1 years among the cases and 50.4 years among the controls.
Menstrual and reproductive variables
When analyses were stratified by smoking status and histology (Table 3) , no association of age at menarche, menstrual cycle length, or number of children with lung cancer was observed for smokers and non-smokers and for each of the cell subtypes. A significant decrease in risk of lung cancer with increasing age at first pregnancy, however, was present for all histological cell subtypes and for smokers, but not for nonsmokers. The proportion of premenopausal women was higher among smoking controls (26%) than among non-smoking controls (17%), partly due to younger ages at interview among smokers (mean age: 58 years among cases and 57 years among controls) compared with non-smokers (62 years and 61 years, respectively). Risk of surgical menopause was slightly higher in non-smokers (OR = 2.35; 95% CI: 1.23-4.49) than in smokers (OR = 1.59; 95% CI: 0.94-2.69). No clear association of lung cancer with either age at natural menopause or age at both natural and surgical menopause was observed in each of the subgroups.
Exogenous hormones
A total of 35% of the cases and 39% of the controls reported having ever used OC (Table 4) , demonstrating a significantly reduced lung cancer risk (OR = 0.69; 95% CI: 0.51-0.92), but no trend in risk with increasing duration of use was observed (P-value for trend: 0.13). Mean age at first use was on average 28.6 years among the cases and 29.0 years among the controls; mean duration of use 9.8 years and 9.3 years, respectively. Since the dosage and composition of hormones in OC dramatically changed over the years, with much higher levels of oestrogens in the 1960s as compared with the 1970s and after 1980, 31 we considered calendar year of first use of OC in three categories. Most of the women started to use OC in the 1960s and 1970s and only a small proportion after 1980. There were no major differences in lung cancer risk between these groups.
A higher proportion of controls (30%) than cases (25%) reported the use of hormones other than OC such as oestrogen replacement therapy, yielding a slightly decreased lung cancer risk (OR = 0.83; 95% CI: 0.64-1.09) after controlling for menopausal status. Mean age at first use was 48.9 years among cases and 47.8 years among controls; mean duration of use 4.9 years and 5.9 years, respectively. Long-term users (ജ7 years) compared with non-users showed a significantly decreased lung cancer risk (OR = 0.59; 95% CI: 0.37-0.93), yet no trend in risk associated with duration of use was present (P-value for trend: 0.19). Women who were treated with HRT for the first time in the 1960s and 1970s, showed a reduction in lung cancer risk while those who started with HRT after 1980 showed no decrease or increase in risk in comparison with non-users.
In Table 5 , risk estimates concerning use of hormones stratified for smokers and non-smokers and for histological cell type are given. Substantially more women used OC among smokers (55% of the controls and 38% of the cases) than among non-smokers (31% and 27%, respectively). This may partly be due to the fact that smoking women belong to a younger generation than non-smoking women. Smoking seems to modify lung cancer risk associated with the use of OC. Among smokers, the OR was significantly reduced for users compared with lifetime non-users (OR = 0.50; 95% CI: 0.34-0.74); whereas no effect was present among non-smoking women (OR = 1.18; 95% CI: 0.78-1.79). For all major histological cell types a reduction in risk was observed, which was most pronounced for small cell lung cancer. In all groups, however, no decrease in lung cancer risk with increasing duration of use was apparent. In the group of smoking women, lung cancer risk by calendar year of first OC use was associated with similar risk estimates at each category, showing OR of 0.47, 0.51, and 0.47 for women who started to use OC in the 1960s, 1970s, and 1980s, respectively. The corresponding OR in the group of non-smoking women were 1.41, 0.88 and 1.63, respectively.
A positive history of HRT was associated with a slightly reduced lung cancer risk that did not differ much between the various histological cell types ( Due to the lack of information on composition of HRT, we analysed separately the group of women with surgical menopause, who are likely to have had hysterectomy and consequently their HRT therapy may have consisted of oestrogens only (Table 6) . A positive history of HRT was associated with a reduced lung cancer risk of OR = 0.8 for all women and among both smoking and non-smoking women. Again long-term users (ജ7 years) showed consistently lowered risk estimates over all sub-groups.
Discussion
The aim of the present study was to examine the role of endogenous and exogenous hormonal factors in the genesis of lung cancer among women. In contrast to tumours of the female reproductive system, hormonal factors showed either no association with lung cancer risk or an inverse association. We found no strong support for an association of age at first menarche, length of menstrual cycle, and number of children with lung cancer. The lack of such an association in the present study is in agreement with other lung cancer studies. 18, [21] [22] [23] Up to now only three case-control studies in Chinese females provided evidence that shorter menstrual cycle length increases the risk of adenocarcinoma. [18] [19] [20] Our data suggest a significant decrease in lung cancer risk with increasing age at first pregnancy. Other studies examining this factor did not observe an association with lung cancer. 18, 21, 23 Since early age at first pregnancy is related to lower social class and our cases tended to have lower levels of education than controls, our finding could be due to residual confounding through social class. When limiting analyses to highly educated women having a professional degree such as college, polytechnic or university, however, lung cancer risk remained reduced (OR = 0.55; 95% CI: 0.21-1.43 among women with age at first pregnancy ജ26 years compared with those aged Ͻ22 years).
Overall we found no clear association between age at natural (or both natural and surgical) menopause and lung cancer risk, and only weak evidence for earlier ages at natural menopause among smoking cases compared with smoking controls. A significant reduction in risk associated with late age at natural and surgical menopause was reported by Wu et al., 23 a Odds ratio adjusted for age, region, log(packyear+1), time since smoking cessation (Ͻ5 years, 5+ years), and educational level (Ͻ10 years, ജ10).
cancer risk with early age at natural and surgical menopause (ഛ40 years). No relation was found in a case-control study among Chinese women. 22 An anti-oestrogenic effect of smoking has been reported, leading to a 1-to 2-year earlier occurrence of natural menopause among smoking women compared with non-smoking women. 32, 33 This was confirmed in our study, showing a mean age at natural menopause of 50.7 years among non-smoking controls, and 49.8 years and 49.0 years among smokers of Ͻ20 pack-years and Ͼ20 pack-years, respectively. In the present study among postmenopausal women, type of menopause was associated with an 1.13-fold non-significantly increased lung cancer risk among women with surgical menopause (not shown). No information was available on type of surgery such as removal of ovaries. Two previous reports found an increase in lung cancer risk after hysterectomy, 23, 34 being highest among women whose ovaries remained intact. 23 A hysterectomy had been suspected as risk factor for lung cancer, because of the potential of traumaassociated lung embolism. 23 Few epidemiological studies examined the role of the use of OC in the aetiology of lung cancer. Wu-Williams et al. 22 noted an OR of 0.8 (95% CI: 0.5-1.2) for lung cancer among women who had used OC as compared with non-users. This finding is consistent with that reported by Taioli et al., 21 (OR = 0.8; 95% CI: 0.5-1.5). A significant trend of reduction in risk of adenocarcinoma with increasing duration of use was noted by Wu et al., 23 although based on short-term users only (averaging 45 months among cases and 61 months in controls). All these studies controlled for smoking and made no distinction in risk between smokers and non-smokers. Our overall smoking adjusted risk estimate is in accordance with previous studies (OR = 0.7; 95% CI: 0.5-0.9), yet we found a significant interaction between smoking status and risk of lung cancer associated with the use of OC, showing a reduction in risk by 50% in smokers only. It is unclear whether this finding is spurious, because no dose-response relationship regarding duration of use was present. Also, women who started to use OC in the 1960s, the years with the highest level of oestrogens in OC, showed a similar lung cancer risk than those who started later when oestrogen levels were drastically reduced. It cannot be excluded that part of the observed reduced risk among smokers may be explained by residual confounding through social class. Differences between East and West German women were not present, neither with respect to the proportion of OC HORMONAL FACTORS AND RISK OF LUNG CANCER 267 users, duration of use, nor the risk estimates. The use of OC was inversely associated with age at first pregnancy among both smokers and non-smokers. Among smokers, at each level of age at first pregnancy a reduced lung cancer risk with the use of OC was found, indicating that OC use seems to be an independent risk factor. Inconsistent findings were available with respect to lung cancer risk associated with HRT. In a large population-based cohort of women who had received HRT, 25 a 30% excess risk for lung cancer was observed (95% CI: 0.9-1.7), which, however, could also have been due to a higher prevalence of smokers in the cohort than in the background population. Two previous case-control studies found no association between HRT and lung cancer. 18, 23 Ettinger et al. 26 reported a lower risk of death from lung cancer in a female cohort of long-term postmenopausal oestrogen replacement hormone users compared with age-matched postmenopausal non-users (relative risk = 0.22; 95% CI: 0.04-1.15, adjusted for current smoking). Our results indicate a lowered lung cancer risk with HRT, particularly among long-term users and independent of cell type. It is difficult to evaluate this effect without data on dosage and composition of hormones. When we limited the analyses to women with surgical menopause, who are most likely to have received oestrogens only, we found a reduction in risk by 50% for longterm users over all sub-groups. The reduction in risk was more pronounced among women starting in the years before 1980 than among those starting later, where probably levels of oestrogens were reduced. It should be noted that use of HRT differed between East and West German women. East German women were treated much less with HRT (16% among controls) than West German women (37% among controls) and for a shorter time period. Lung cancer risk associated with a positive history of HRT differed slightly between East German (OR = 1.10; 95% CI: 0.61-1.96) and West German women (OR = 0.80; 95% CI: 0.59-1.08).
A 70% significant excess risk of adenocarcinoma (95% CI: 1.0-2.8) for HRT users versus non-users including a nonsignificant increase in lung cancer risk with increasing duration of use was demonstrated by Taioli et al. 21 Interestingly, the increase in risk was primarily seen among smokers, while no effect was present among non-smokers. 21 Some studies which provided evidence for a higher susceptibility of lung cancer in women than men given a similar level of tobacco smoke 3 hypothesized that this observed positive synergism between HRT and smoking might be some possible explanation. Our results contradict a positive synergism of HRT with smoking. Several factors may contribute to these differences. First our study subjects were more likely to report long-term use than those of Taioli; 21 second, composition and dosage of hormones may differ in both studies (unfortunately both studies did not collect this information); third, differences in smoking habits or residual confounding due to social class may produce different risk estimates.
There is increasing evidence that oestrogens may play a role in the genesis of lung cancer, yet the mechanism is unclear. Experimental studies suggest the presence of oestrogen and other steroid receptors in lung tissue. [5] [6] [7] [8] 35, 36 Steroids are known to be involved in the differentiation and metabolism of pulmonary epithelial cells. The presence of these receptors has been suggested as indicative of their common role in the regulation of cancer growth in various organs 36 and of potential hormonal responsiveness of these tumours. 20 Since adenocarcinomas showed a significantly higher incidence of steroid receptors compared with other lung cancer cell types, 4 some investigators hypothesized that the greater proportion of adenocarcinoma among female compared with male cases 1 may be in part due to endocrine-related factors. In addition, a greater proportion of oestrogen receptors has been detected in females than in males. 37 In the present study, however, no major One of the main strengths of this study is the large sample size of lung cancer cases and controls that made the overall risk estimates relatively stable and allowed stratification by smoking status and histology. All interviews were conducted with the subjects themselves in face-to-face interviews, in contrast to studies in which surrogates were used. All cases were histologically or cytologically verified as tumours that originated in the lung. In addition, an independent review of about 75% of the diagnosed material was completed, in order to classify the cell type uniformly. Moreover, we controlled for most potential confounders.
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Nevertheless, there are several limitations in our study. Some potential methodological problems concern the low response rate among controls and recruitment of cases. In Germany, cancer patients had to be recruited via study hospitals, since no overall cancer registry existed, thus the extent of representativeness of our cases is not measurable. In previous analyses based on the former East German cancer registry we estimated a coverage of about 50% for the eastern study area. A selection bias due to the poor response among controls cannot be completely ruled out. In a sub-sample of refusals, a non-response-analysis was conducted. Non-response was mainly due to refusal of longterm measurements of radon (1 year) required in the subjects' homes (38%), no time for interview and organization of the measurement (13%), followed by illness (13%) and other reasons. As the controls tended to be more highly educated than the cases and there may be a positive correlation between low social class and some of the hormonal factors such as young age at first pregnancy and less frequent use of hormones, special attention has been given to a potential selection bias by controlling for educational level. However, uncontrolled residual confounding by differential socioeconomic status and life style cannot be excluded and could have resulted in somewhat lowered risk estimates. Another potential weakness of our study is the lack of information on type and dosage of hormones. Since this study was primarily conducted to investigate the effects of residential radon on lung cancer risk, no detailed information on hormones was collected. Some of the observed differences in risk between smokers and nonsmokers might be explained by differences in type and dosage of hormones.
Conclusion
Our study provides evidence that some hormonal factors, such as use of OC or other hormones, may reduce lung cancer risk to some extent and that the reduction is more pronounced among smokers. Yet, no clear dose-response relationship with duration of use was apparent. The previously reported positive synergism between smoking and HRT could not be confirmed in our study. Risk of lung cancer associated with the various hormonal factors did not differ much between histological cell subtypes. 
